MedPath

BANZEL

BANZEL

Discontinued
DIN Number

02388685

Drug Class

Human

Market Date

N/A

Company
HC

EISAI LIMITED

Product Information

Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.

Product Details

Health Canada regulatory and product classification information

Regulatory Identifiers
DIN Number02388685
AIG Number0152938004
Classification & Schedule
C
Drug Class
Human
S
Schedule
Prescription
A
ATC Code
N03AF03 RUFINAMIDE
Product Specifications
Dosage FormSuspension
Route of AdministrationOral
AHFS Classification28:12.92
Health Canada Classification

ACTIVE INGREDIENTS (1)

RUFINAMIDEActive
Strength: 40 MG / ML
Monograph: RUFINAMIDE

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.